CatalogResearchCommunityTools
Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Growth Hormone Secretagogue Evidence Grade: B (Human Clinical Data)

Hexarelin Protocol Guide

Hexarelin (Examorelin) is the strongest of the growth hormone-releasing peptides (GHRPs), producing the most potent GH release per dose among its class. It acts on the ghrelin receptor (GHS-R1a) to stimulate pituitary growth hormone secretion, with additional cardioprotective effects observed in research. Unlike Ipamorelin, Hexarelin can also raise cortisol and prolactin levels, particularly at higher doses, and is prone to receptor desensitization with prolonged use. This protocol covers reconstitution from a 5mg vial with 2mL bacteriostatic water, subcutaneous dosing at 100mcg before bed, desensitization cycling strategies, and stacking with GHRH analogs for amplified GH release.

Protocol Overview

Compound
Hexarelin (Examorelin, Hexarelin Acetate)
Category
Growth Hormone Secretagogue (GHRP)
Mechanism
Activates ghrelin receptor (GHS-R1a) on pituitary somatotrophs, triggering robust GH release; also provides cardioprotective effects independent of GH pathway
Structure
Hexapeptide (6 amino acids), His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2
Half-Life
~60-70 minutes
Vial Size
5mg lyophilized powder
Route
Subcutaneous injection
Frequency
Once daily (before bed)
Cycle Length
4 weeks on / 4 weeks off

Dosing Protocol

ProtocolDoseFrequencyRouteDuration
Standard GH Release100 mcg1x daily (before bed)Subcutaneous4 weeks on / 4 off
Conservative Start50 mcg1x daily (before bed)Subcutaneous1-2 weeks, then assess
Saturation Dose200 mcg1x daily (before bed)Subcutaneous4 weeks max

Key principle: Hexarelin is the most potent GHRP but is prone to desensitization. Cycle 4 weeks on / 4 weeks off to maintain receptor sensitivity. Administer before bed to synergize with natural nocturnal GH pulses. Avoid administering with food as carbohydrates and fats blunt GH release.

Reconstitution Instructions

Materials Needed

  • Hexarelin 5mg lyophilized vial
  • Bacteriostatic water (2mL)
  • 3mL mixing syringe (18-20ga)
  • Insulin syringes (29-31ga) for dosing
  • Alcohol swabs

Reconstitution Steps

  1. Clean vial stopper with alcohol
  2. Draw 2mL bacteriostatic water
  3. Inject slowly down the vial wall
  4. Gently swirl (never shake)
  5. Wait 5 minutes for full dissolution
  6. Concentration: 2,500 mcg/mL
DoseVolume (2mL recon)Insulin Syringe
50 mcg0.02 mL2 units
100 mcg0.04 mL4 units
200 mcg0.08 mL8 units
500 mcg0.20 mL20 units

Administration Guide

Injection Sites

  • Abdomen: Primary site, subcutaneous
  • Thigh: Outer thigh, alternate sides
  • Upper arm: Back of arm, alternate

Timing & Storage

  • Timing: Before bed on empty stomach (2+ hrs post-meal)
  • Fasted state: Important - carbs/fats blunt GH release
  • Vial duration: ~50 days at 100mcg/day
  • Storage (reconstituted): Refrigerate 2-8°C, use within 30 days
  • Do not freeze reconstituted solution

Expected Timeline

Day 1-3
Immediate GH release within 15-30 minutes of injection. Some subjects report improved sleep depth and vivid dreams from the first dose. Mild hunger increase possible.
Week 1-2
Improved sleep quality and recovery become consistent. Skin texture improvements beginning. Some subjects notice enhanced fat mobilization and improved workout recovery.
Week 3-4
Peak GH output before desensitization begins. Measurable body composition changes. Improved joint and tendon health. Complete the cycle and begin the off-period.
Off Period
4-week off-period to restore GHS-R1a receptor sensitivity. May substitute with Ipamorelin (which has lower desensitization risk) during off-weeks if desired.

Side Effects & Monitoring

Common Side Effects

  • Increased appetite / hunger (ghrelin mimicry)
  • Water retention and mild bloating
  • Numbness/tingling in hands (carpal tunnel-like, at higher doses)
  • Injection site redness (mild)
  • Elevated cortisol and prolactin

Hexarelin has more side effects than Ipamorelin due to its broader receptor activation. Cortisol and prolactin elevations are dose-dependent and typically manageable at standard doses.

Precautions

  • Monitor cortisol and prolactin levels during use
  • Desensitization occurs with continuous use beyond 4-8 weeks
  • May elevate IGF-1 - monitor in subjects with cancer history
  • Not recommended during pregnancy or breastfeeding
  • Use caution with diabetes - GH can affect insulin sensitivity

Stacking Recommendations

Compatible Compounds

  • CJC-1295 No DAC: GHRH + GHRP synergy for amplified GH pulse
  • Ipamorelin: Use during Hexarelin off-weeks for continuous GH support
  • BPC-157: Tissue repair enhancement during recovery
  • TB-500: Systemic recovery and healing
  • DSIP: Sleep quality support during GH protocols

Popular Stacks

  • GH Blast: Hexarelin 100mcg + CJC-1295 No DAC 100mcg before bed
  • Recovery: Hexarelin + BPC-157 250mcg + TB-500 750mcg
  • Rotating GH: Hexarelin 4 wks on, Ipamorelin 4 wks on

Blood Work Recommendations

PanelMarkersTiming
GH AxisIGF-1, GH (fasting)Baseline, Week 4
HormonesCortisol (AM), prolactinBaseline, Week 2, Week 4
MetabolicFasting glucose, insulin, HbA1cBaseline, Week 4
Basic PanelCBC, CMP, lipidsBaseline, Week 4

IGF-1 is the primary marker for sustained GH output. Cortisol and prolactin monitoring is especially important with Hexarelin since it elevates these more than other GHRPs like Ipamorelin or GHRP-2.

Related Resources

Sermorelin Protocol HGH (Somatropin) Protocol CJC-1295 + Ipamorelin Protocol Dosing Calculator Reconstitution Calculator Bloodwork Planner Stack Checker Peptide Catalog
★ OFFICIAL SPONSOR
BioRoot AI
Free Functional Assessment
AI-powered root cause analysis & care plan
Start Free
Paid partnership · Learn more
Share & Save
𝕏 Share on Twitter 📱 Share on Reddit 💬 WhatsApp ✉️ Email 🔗 Copy Link 🖨️ Print / Save PDF Save to Favorites